Brief: Bergenbio And Oslo University Hospital Announce The AXL Inhibitor

Oncoinvent ASA

27/01/2022 06:10

Jan 27 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO AND OSLO UNIVERSITY HOSPITAL ANNOUNCE THE AXL
INHIBITOR
    * AGREEMENT TO STUDY BERGENBIO AXL INHIBITOR BEMCENTINIB, IN
HOSPITALISED COVID-19 PATIENTS.

Source text for Eikon:  ID:nObiwJmx4a 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))